Quajune Chance, - Pharmacist in Bethany, OK

Quajune Chance, is a Pharmacist based in Bethany, Oklahoma. Quajune Chance is licensed to practice in Oklahoma (license number I-10733) and his current practice location is 2316 N Rockwell Ave, Bethany, Oklahoma. He can be reached at his office (for appointments etc.) via phone at (405) 440-0342.

NPI number for Quajune Chance is 1043922081 and his current mailing address is 4317 Sw 22nd St Apt 1902, Oklahoma City, Oklahoma. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1043922081.

Contact Information

Quajune Chance,
2316 N Rockwell Ave,
Bethany, OK 73008-5852
(405) 440-0342
Not Available

Healthcare Provider's Profile

Full NameQuajune Chance
GenderMale
SpecialityPharmacist
Location2316 N Rockwell Ave, Bethany, Oklahoma
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1043922081
  • Provider Enumeration Date: 12/21/2022
  • Last Update Date: 01/02/2023

Medical Identifiers

Medical identifiers for Quajune Chance such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1043922081NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist I-10733 (Oklahoma)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Quajune Chance is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Quajune Chance,
4317 Sw 22nd St Apt 1902,
Oklahoma City, OK 73108-1942

Ph: (215) 789-0745
Quajune Chance,
2316 N Rockwell Ave,
Bethany, OK 73008-5852

Ph: (405) 440-0342

News Archive

Aileron Therapeutics, Roche partner to develop, commercialise Stapled Peptide Therapeutics

Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche's key therapeutic areas, which include oncology, virology, inflammation, metabolism and CNS.

IRS rule could keep working-class families from affordable coverage

An IRS rule could mean some working-class families may not be able to afford employer-sponsored insurance nor qualify for federal subsidies under the health law, leaving a key part of America uninsured. Childless adults, however, are in line for significant health insurance coverage gains under the health law's Medicaid expansion.

Study uncovers marijuana's potential to treat autoimmune diseases

A team of University of South Carolina researchers led by Mitzi Nagarkatti, Prakash Nagarkatti and Xiaoming Yang have discovered a novel pathway through which marijuana can suppress the body's immune functions. Their research has been published online in the Journal of Biological Chemistry.

Occupational exposure to synthetic fibers – a possible link with breast cancer

According to a recent report published in Occupational and Environmental Medicine, scientists have found that women during her mid 30's exposed to petrol products and synthetic fibers could treble the risk of developing breast cancer after menopause. According to the report, "Occupational exposure to nylon and acrylic fibers as well as to polycyclic aromatic hydrocarbons has higher risk of developing postmenopausal breast cancer."

BIO President issues statement on FDA guidance for biosimilars

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the newly released U.S. Food and Drug Administration (FDA) guidance for the review and approval of biosimilars.

Read more News

› Verified 8 days ago


Pharmacist in Bethany, OK

Katelyn Lindsey Owen,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2316 N Rockwell Ave, Bethany, OK 73008
Phone: 405-440-0342    
Thanh Nha Duong,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 7101 Nw 23rd St, Bethany, OK 73008
Phone: 405-789-2596    
Velda Journey, D.PH.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 6801 Nw 39th Expy, Bethany, OK 73008
Phone: 405-789-2453    
Jason Scott Girard, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2316 N Rockwell Ave, Bethany, OK 73008
Phone: 405-440-0342    
Tanya Billingsley,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2316 N Rockwell Ave, Bethany, OK 73008
Phone: 405-440-0342    
Mr. Scott E Terrell, DPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2316 N Rockwell Ave, Bethany, OK 73008
Phone: 405-440-0342    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.